The Centers for Disease Control and Prevention is accepting comments through April 11 on a draft updated clinical practice guideline for prescribing opioids for chronic pain. The guideline recommendations are voluntary and intended to improve communication between providers and patients and empower them to make informed, patient-centered decisions related to safe and effective pain care, CDC said. For more on the process and timeline for updating the guideline, click here. 

Related News Articles

Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…
Headline
The Food and Drug Administration April 3 announced that it will require manufacturers of opioid analgesics used in outpatient settings to modify their Risk…
Headline
In response to Drug Enforcement Administration proposals to limit telehealth prescriptions for buprenorphine and other controlled substances after…
Headline
The Food and Drug Administration yesterday issued a report offering recommendations to address the opioid crisis and the role of analgesic oversight in…